$CSBR
CHAMPIONS ONCOLOGY, INC.

2021 Q3 Form 10-Q Financial Statement

#000162828021018495 Filed on September 13, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3 2020 Q1
Revenue $11.25M $9.547M $9.012M
YoY Change 17.87% 41.71% 40.16%
Cost Of Revenue $5.396M $5.336M $4.325M
YoY Change 1.12% 42.22% 26.13%
Gross Profit $5.857M $4.211M $4.687M
YoY Change 39.09% 41.07% 56.18%
Gross Profit Margin 52.05% 44.11% 52.01%
Selling, General & Admin $3.728M $2.590M $2.863M
YoY Change 43.94% 12.8% 36.2%
% of Gross Profit 63.65% 61.51% 61.08%
Research & Development $2.304M $1.597M $1.391M
YoY Change 44.27% 22.56% 9.61%
% of Gross Profit 39.34% 37.92% 29.68%
Depreciation & Amortization $317.0K $224.0K $184.0K
YoY Change 41.52% 54.48% 44.88%
% of Gross Profit 5.41% 5.32% 3.93%
Operating Expenses $6.032M $4.187M $8.579M
YoY Change 44.06% -43.04% 26.16%
Operating Profit -$175.0K $24.00K $433.0K
YoY Change -829.17% -103.91% -217.03%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $17.00K $64.00K -$14.00K
YoY Change -73.44% -633.33% -1500.0%
Pretax Income -$158.0K $88.00K $419.0K
YoY Change -279.55% -114.06% -213.55%
Income Tax $14.00K $13.00K $12.00K
% Of Pretax Income 14.77% 2.86%
Net Earnings -$172.0K $75.00K $75.00K
YoY Change -329.33% -111.7% -120.33%
Net Earnings / Revenue -1.53% 0.79% 0.83%
Basic Earnings Per Share -$0.01 $0.01 $0.03
Diluted Earnings Per Share -$0.01 $0.01 $0.03
COMMON SHARES
Basic Shares Outstanding 13.40M shares 12.73M shares 11.75M shares
Diluted Shares Outstanding 13.40M shares 14.23M shares 13.67M shares

Balance Sheet

Concept 2021 Q3 2020 Q3 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.998M $6.940M $3.280M
YoY Change -42.39% 215.45% -0.91%
Cash & Equivalents $4.000M $6.943M $3.282M
Short-Term Investments
Other Short-Term Assets $864.0K $360.0K $360.0K
YoY Change 140.0% 38.46% 20.0%
Inventory
Prepaid Expenses
Receivables $7.733M $5.039M $4.493M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $12.60M $12.34M $8.130M
YoY Change 2.05% 94.39% 8.01%
LONG-TERM ASSETS
Property, Plant & Equipment $6.763M $4.434M $3.246M
YoY Change 52.53% 42.43% 25.91%
Goodwill $335.0K $335.0K $669.0K
YoY Change 0.0% -49.93% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $86.00K $36.00K $128.0K
YoY Change 138.89% -71.88% -6.57%
Total Long-Term Assets $15.51M $10.48M $6.945M
YoY Change 48.05% 49.41% 105.23%
TOTAL ASSETS
Total Short-Term Assets $12.60M $12.34M $8.130M
Total Long-Term Assets $15.51M $10.48M $6.945M
Total Assets $28.11M $22.82M $15.08M
YoY Change 23.17% 70.78% 38.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.345M $2.675M $2.215M
YoY Change 25.05% -1.83% 4.68%
Accrued Expenses $1.981M $2.154M $978.0K
YoY Change -8.03% 179.74% 52.57%
Deferred Revenue $5.481M $5.669M $4.586M
YoY Change -3.32% 42.83% -2.9%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $70.00K $180.0K
YoY Change 600.0% -18.18%
Total Short-Term Liabilities $11.68M $11.09M $8.446M
YoY Change 5.33% 39.79% 9.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $242.0K $178.0K $151.0K
YoY Change 35.96% 17.88% 0.0%
Total Long-Term Liabilities $242.0K $178.0K $151.0K
YoY Change 35.96% 17.88% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.68M $11.09M $8.446M
Total Long-Term Liabilities $242.0K $178.0K $151.0K
Total Liabilities $20.57M $17.31M $11.90M
YoY Change 18.85% 48.76% 38.54%
SHAREHOLDERS EQUITY
Retained Earnings -$72.70M -$72.60M -$70.60M
YoY Change 0.14% 1.82% 0.28%
Common Stock $80.24M $78.11M $73.80M
YoY Change 2.73% 6.9% 1.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.538M $5.513M $5.513M
YoY Change
Total Liabilities & Shareholders Equity $28.11M $22.82M $15.08M
YoY Change 23.17% 70.78% 38.16%

Cashflow Statement

Concept 2021 Q3 2020 Q3 2020 Q1
OPERATING ACTIVITIES
Net Income -$172.0K $75.00K $75.00K
YoY Change -329.33% -111.7% -120.33%
Depreciation, Depletion And Amortization $317.0K $224.0K $184.0K
YoY Change 41.52% 54.48% 44.88%
Cash From Operating Activities $216.0K -$715.0K $280.0K
YoY Change -130.21% 156.27% -76.86%
INVESTING ACTIVITIES
Capital Expenditures $907.0K $718.0K -$170.0K
YoY Change 26.32% -4.14% -15.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $90.00K
YoY Change -100.0%
Cash From Investing Activities -$907.0K -$626.0K -$170.0K
YoY Change 44.89% -16.42% -15.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $2.000K -$58.00K 390.0K
YoY Change -103.45% 728.57% 11.43%
NET CHANGE
Cash From Operating Activities $216.0K -$715.0K 280.0K
Cash From Investing Activities -$907.0K -$626.0K -170.0K
Cash From Financing Activities $2.000K -$58.00K 390.0K
Net Change In Cash -$689.0K -$1.399M 500.0K
YoY Change -50.75% 35.17% -63.24%
FREE CASH FLOW
Cash From Operating Activities $216.0K -$715.0K $280.0K
Capital Expenditures $907.0K $718.0K -$170.0K
Free Cash Flow -$691.0K -$1.433M $450.0K
YoY Change -51.78% 39.4% -68.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 dei Amendment Flag
AmendmentFlag
false
CY2021Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000771856
CY2021Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
CY2021Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2020Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2020Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2021Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2021Q3 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2021Q3 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2020Q3 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2021Q3 dei Document Type
DocumentType
10-Q
CY2020Q3 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2021Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q3 dei Document Period End Date
DocumentPeriodEndDate
2021-07-31
CY2021Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q3 dei Entity File Number
EntityFileNumber
001-11504
CY2021Q3 dei Entity Registrant Name
EntityRegistrantName
CHAMPIONS ONCOLOGY, INC.
CY2021Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-1401755
CY2021Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
One University Plaza, Suite 307
CY2021Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07601
CY2021Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Hackensack
CY2021Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2021Q3 dei City Area Code
CityAreaCode
201
CY2021Q3 dei Local Phone Number
LocalPhoneNumber
808-8400
CY2021Q3 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2021Q3 dei Trading Symbol
TradingSymbol
CSBR
CY2021Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q3 dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13422106 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3998000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4687000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7733000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6986000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
864000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
957000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
12595000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
12630000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8329000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8521000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6763000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6090000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
86000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
335000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
335000 USD
CY2021Q3 us-gaap Assets
Assets
28108000 USD
CY2021Q2 us-gaap Assets
Assets
27591000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3345000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1894000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1981000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2231000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
854000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
818000 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5481000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6256000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11676000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11199000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8652000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8783000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
242000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
181000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
20570000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
20163000 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13415066 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13415066 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13414066 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13414066 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
13000 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
13000 USD
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
80227000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
79945000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72702000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72530000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
7538000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
7428000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28108000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27591000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11253000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9547000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5396000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5336000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2304000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1597000 USD
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1574000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1208000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2154000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1382000 USD
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
11428000 USD
CY2020Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
9523000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-175000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
24000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
64000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-158000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
88000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-172000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
75000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13401929 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12727275 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13401929 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14231641 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
7428000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
280000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
2000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-172000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
7538000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
5318000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
120000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
75000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
5513000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-172000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
75000 USD
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
280000 USD
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
120000 USD
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
317000 USD
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
277000 USD
CY2021Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
4000 USD
CY2020Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2021Q3 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0 USD
CY2020Q3 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
75000 USD
CY2021Q3 csbr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
245000 USD
CY2020Q3 csbr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-67000 USD
CY2021Q3 csbr Reversal Of Provision For Doubtful Accounts
ReversalOfProvisionForDoubtfulAccounts
78000 USD
CY2020Q3 csbr Reversal Of Provision For Doubtful Accounts
ReversalOfProvisionForDoubtfulAccounts
-6000 USD
CY2021Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
825000 USD
CY2020Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
263000 USD
CY2021Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-93000 USD
CY2020Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-25000 USD
CY2021Q3 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
70000 USD
CY2020Q3 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 USD
CY2021Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1372000 USD
CY2020Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-465000 USD
CY2021Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-250000 USD
CY2020Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-348000 USD
CY2021Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
15000 USD
CY2020Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
0 USD
CY2021Q3 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
62000 USD
CY2020Q3 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1000 USD
CY2021Q3 csbr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
150000 USD
CY2020Q3 csbr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-157000 USD
CY2021Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-775000 USD
CY2020Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-146000 USD
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
216000 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-715000 USD
CY2021Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
907000 USD
CY2020Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
718000 USD
CY2021Q3 csbr Proceeds From Refund Of Security Deposit
ProceedsFromRefundOfSecurityDeposit
0 USD
CY2020Q3 csbr Proceeds From Refund Of Security Deposit
ProceedsFromRefundOfSecurityDeposit
92000 USD
CY2021Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-907000 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-626000 USD
CY2021Q3 csbr Proceeds From Exercise Of Options And Warrants
ProceedsFromExerciseOfOptionsAndWarrants
2000 USD
CY2020Q3 csbr Proceeds From Exercise Of Options And Warrants
ProceedsFromExerciseOfOptionsAndWarrants
0 USD
CY2021Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 USD
CY2020Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
58000 USD
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2000 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-58000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-689000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1399000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4687000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8342000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3998000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6943000 USD
CY2021Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2020Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3872000 USD
CY2021Q3 csbr Receipt Of No Cost Equipment
ReceiptOfNoCostEquipment
79000 USD
CY2020Q3 csbr Receipt Of No Cost Equipment
ReceiptOfNoCostEquipment
0 USD
CY2021Q3 csbr Number Of Operating Subsidiaries
NumberOfOperatingSubsidiaries
3 subsidiary
CY2021Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 USD
CY2021Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-172000 USD
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
216000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72700000 USD
CY2021Q3 csbr Working Capital Deficit
WorkingCapitalDeficit
919000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4000000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-172000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
75000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13401929 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12727275 shares
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-172000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
75000 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-172000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
75000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13401929 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12727275 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1504366 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13401929 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14231641 shares
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1734428 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2276263 shares
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
181000 USD
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
181000 USD
CY2021Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
3000 USD
CY2021Q3 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
3000 USD
CY2021Q3 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 USD
CY2020Q3 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 USD
CY2021Q3 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
0 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13000 USD
CY2021Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
4465000 USD
CY2021Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
4304000 USD
CY2021Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
3684000 USD
CY2021Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
3020000 USD
CY2021Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
8149000 USD
CY2021Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
7324000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
416000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
338000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7733000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6986000 USD
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
5481000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6256000 USD
CY2021Q3 us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
The majority of the Company's revenue arrangements are service contracts that are complete within a year or less. There are a few contracts that range in duration between 1 and 3 years.
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11253000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9547000 USD
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
11030000 USD
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
10046000 USD
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
4267000 USD
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
3956000 USD
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
6763000 USD
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
6090000 USD
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
317000 USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
224000 USD
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
343000 USD
CY2021Q2 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
343000 USD
CY2021Q3 csbr Finance Lease Depreciation And Amortization Expenses
FinanceLeaseDepreciationAndAmortizationExpenses
0 USD
CY2020Q3 csbr Finance Lease Depreciation And Amortization Expenses
FinanceLeaseDepreciationAndAmortizationExpenses
53000 USD
CY2021Q3 us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
40000 USD
CY2020Q3 us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
0 USD
CY2021Q3 us-gaap Hosting Arrangement Service Contract Implementation Cost Capitalized Accumulated Amortization
HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization
1200000 USD
CY2021Q2 us-gaap Hosting Arrangement Service Contract Implementation Cost Capitalized Accumulated Amortization
HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization
991000 USD
csbr Finance Lease Cost
FinanceLeaseCost
149000 USD
CY2021Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0 USD
CY2018Q3 csbr Finance Lease Cost
FinanceLeaseCost
266000 USD
CY2020Q2 csbr Finance Lease Number Of Right Of Use Assets Acquired
FinanceLeaseNumberOfRightOfUseAssetsAcquired
2 asset
CY2021Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0 USD
CY2020 csbr Finance Lease Cost
FinanceLeaseCost
231000 USD
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
53000 USD
CY2020Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0 USD
CY2021Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
280000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
120000 USD
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0082
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0039
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.6594
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.6621
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7264
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.33
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.85
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1653646 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.96
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y4M24D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11384000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
85532 shares
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.01
CY2021Q3 csbr Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y10M24D
CY2021Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.10
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3750 shares
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
10.64
CY2021Q3 csbr Share Based Compensation Arrangement By Share Based Payment Award Options Canceled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod
0 shares
CY2021Q3 csbr Share Based Compensation Arrangements By Share Based Payment Award Options Canceled In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1734428 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.19
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y4M24D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11063000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1734428 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.19
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y4M24D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
11063000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1363336 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.50
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M6D
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
9666000 USD
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
452000 USD
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
307000 USD
CY2020Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P6M
CY2020Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P6M
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8329000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8521000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
854000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
818000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8652000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8783000 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y6M18D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0577
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1913000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2538000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2678000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2721000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2765000 USD
CY2021Q3 csbr Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
7932000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
20547000 USD
CY2021Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
4400 USD

Files In Submission

Name View Source Status
0001628280-21-018495-index-headers.html Edgar Link pending
0001628280-21-018495-index.html Edgar Link pending
0001628280-21-018495.txt Edgar Link pending
0001628280-21-018495-xbrl.zip Edgar Link pending
csbr-20210731.htm Edgar Link pending
csbr-20210731.xsd Edgar Link pending
csbr-20210731_cal.xml Edgar Link unprocessable
csbr-20210731_def.xml Edgar Link unprocessable
csbr-20210731_htm.xml Edgar Link completed
csbr-20210731_lab.xml Edgar Link unprocessable
csbr-20210731_pre.xml Edgar Link unprocessable
csbrq1731202110-qex311.htm Edgar Link pending
csbrq1731202110-qex312.htm Edgar Link pending
csbrq1731202110-qex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending